Detailed Information on Tumor Mutational Burden Our tumour mutational load assay has been designed in response to the need to determine if treatment utilising immune checkpoint inhibitors are likely to be of benefit in your particular clinical circumstances. In some cancer types, the available drugs for this treatment are not listed on the Australian Pharmaceutical … Continue reading Tumour Mutational Burden